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Abstract 
 
Claims of benefits of aromatherapy for cancer patients include reduced anxiety levels and relief of emotional stress, 
pain, muscular tension and fatigue. The objective of this paper is to provide an updated descriptive, systematic review of evidence 
from pre-clinical and clinical trials assessing the benefits and safety of aromatherapy for cancer patients. Literature databases such 
as Medline (via Ovid), the Cochrane database of systematic reviews, Cochrane Central were searched from their inception until 
October 2010. Only studies on cancer cells or cancer patients were included. There is no long lasting effect of aromatherapy 
massage, while short term improvements were reported for general well being, anxiety and depression up to 8 weeks after 
treatment. The reviewed studies indicate short-term effects of aromatherapy on depression, anxiety and overall wellbeing.  
Specifically, some clinical trials found an increase in patient-identified symptom relief, psychological wellbeing and improved 
sleep. Furthermore, some found a short-term improvement (up to 2 weeks after treatment) in anxiety and depression scores and 
better pain control. Although essential oils have generally shown minimal adverse effects, potential risks include ingesting large 
amounts (intentional misuse); local skin irritation, especially with prolonged skin contact; allergic contact dermatitis; and 
phototoxicity from reaction to sunlight (some oils). Repeated topical administration of lavender and tea tree oil was associated 
with reversible prepubertal gynecomastia. 
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Introduction 
 
Aromatherapy encompasses the use of essential oils derived from different types of plant sources for a variety of 
application methods. Generally, the whole fresh plant (not crushed or powdered) is used for the essential oil distillation process.  
The specific ingredients of an essential oil are derived from plant materials or parts that are claimed to possess therapeutic 
properties. Essential oils are “the steam distillate of aromatic plants” (Tisserand and Balacs, 1995). They have been described as 
“the volatile, organic constituents of fragrant plant matter and contribute to both flavor and fragrance and are extracted either by 
distillation or by cold pressing (expression)" (Tisserand and Balacs, 1995). The history of distillation of essential oils started with 
the medieval physician Avicenna (Abu Ali al-Hussein Ibn Abdallah Ibn Sina; 980 - 1037) from Persia who invented the process 
of distillation and was probably the first to distil oil of the rose plant (Tisserand, 1988). Today, approximately 40 different oils 
derived from plants are used in aromatherapy. Lavender, rosemary, eucalyptus, chamomile, marjoram, jasmine, peppermint, 
lemon, ylang ylang, and geranium are some of the most popular. 
 The term ‘aromatherapy’ was coined by French chemist and perfumiér René Maurice Gattefossé in the 1920s and is a 
subcategory of ‘herbal medicine’ (Gattefosse, 1993). Gattefossé's book was published in 1937. He suggested that aromatherapy 
could be used to treat diseases in virtually every organ system, citing mostly anecdotal and case-based evidence. In the 1960s, 
aromatherapy was revived by the French homeopath Dr. Maury, and in the 1980s it increased in popularity in the United States. It 
is fairly well-established in Australia, Canada, France, Germany, New Zealand, Switzerland and the UK. 
There are various forms of application.  Most commonly, oils are applied topically in diluted forms, often together with 
a carrier oil as part of massage therapy to manipulate the soft tissue of the body, or by using an incense burner for inhalation of 
the aroma. Essential oils may be inhaled by adding a few drops to steaming water, thereafter an atomizer or humidifier spreads the 
aroma throughout the room. Certain aromatherapy oils are also ingested through teas, whereas others can be added to bathwater or 
pillows, or used to make ointments, creams and compresses. Some aromatherapists argue that the use of certain herbs in food can 
also be considered part of aromatherapy, although this should be considered as a specific alimentation rather than a precise use as 
essential oils.  
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Essential oils are supposed to improve physical and emotional wellbeing (www.cancer.gov/cancertopics/-
pdq/cam/aromatherapy/healthprofessional.page1). A wide range of claims for the effect of certain oils have been put forward, 
ranging from: to affect a patient’s "subtle body"; bring balance to a distinct “chakra”; restore harmony to the “energy flow”; 
become centered; contribute to “spiritual growth”; alter mood and improve overall health; to more specific claims such as having 
anticonvulsive and spasmolytic properties (www.skepdic.com/aroma.html). It has been suggested that the topical application of 
aromatic oils may exert antibacterial, anti-inflammatory, and analgesic effects. 
For cancer patients, claims of benefits include reduced anxiety levels and relief of emotional stress, pain, muscular 
tension and fatigue (Fellowes et al, 2004). Some of these alleged outcomes are vaguely defined. 
The chemical properties and composition of a specific type of oil gives it whatever therapeutic qualities the essential oil might 
have. A number of theories try to explain the mechanism of action of aromatherapy and essential oils. The most often cited is the 
proposed connection between olfaction and the limbic system in the brain as the basis for the effects of aromatherapy on mood 
and emotions (Smith, 1999). These assertions have been contested by the biochemistry and psychology communities, which take 
a different view of the possible mechanism of action of odors on the human brain and do not differentiate the odors produced by 
essential oils from those of synthetic fragrances (Perry and Perry, 2006). Little is said about proposed mechanisms for its effects 
on other parts of the body. Unfortunately, many of these assumptions are primarily theoretical because of the lack of significant 
research addressing this topic. There is also a lack of in-depth neurophysiological studies on the nature of olfaction and its link to 
the limbic system. 
An individual’s expectation and subjective perception of oil supposedly influences treatment outcomes, including 
whether or not an individual has previous experience with a particular scent and whether it is perceived as pleasurable 
(www.sirc.org/publik/small.pdf). Marked association of odors with emotional response has been shown to be due to the 
prominence of afferent links from the olfactory bulb to the amygdala, where emotional significance is attached to incoming 
stimuli (Clark and Boutros, 1999).   
Neuro-chemical aspects involve a suggested inhibition of glutamate binding, γ-amiobutyric acid (GABA) augmentation 
and acetylcholine receptor binding. As an example, the main terpenoid component of lavender oil is linalool. Linalool has been 
shown to inhibit glutamate binding in rats (Watt, 1995) and inhaled lavender oil reduces electroshock-induced convulsions in 
mice, which suggests augmentation of GABA (Yamada et al, 1994). Linalool’s inhibitory effect was demonstrated to be dose 
dependent with increasing concentrations; all response was abolished by the use of 6.5 mM linalool. This modifying effect on the 
glutamatergic system is comparable with phenobarbital, a known anticonvulsant (Elisabetsky et al, 1995). Further evidence for 
this mechanism comes from the finding of a potentiation of GABA receptors expressed in Xenopus oocytes by lavender oil 
components (Aoshima et al, 2001). 
It has been suggested that compounds from essential oils may enter the body (via the olfactory mucosa or the 
bloodstream by lung absorption) and may directly influence the brain (Watt, 1995). It is suggested that there are scent receptors in 
the nose which send chemical messages via the olfactory nerve to the brain’s limbic region. This in return can affect a person’s 
emotional responses, heart rate, blood pressure and breathing. 
Generally speaking, the application of aromatherapy is suggested to help patients cope with stress, chronic pain, nausea 
and depression. One can assume both direct effects of the oils, but also positive expectations of the patients. Furthermore it has 
been suggested that the use of essential oils can relieve bacterial infections (Geda, 1995), stimulate the immune system (Komori et 
al, 1995), help to fight colds, flues and sore throats (Hasani et al, 2003), improve urine production (Morimoto and Shibata, 2010), 
increase circulation (Shiina et al, 2008) and aid in the healing of cystitis (Eriksen, 2000), herpes simplex (Buckle, 2002), acne 
(Eriksen, 2000), headaches (Eriksen, 2000), indigestion (Schnaubelt, 1999), premenstrual syndrome (Eriksen, 2000), muscle 
tension (Lis-Balchin et al, 2000), and even cancer (Fellowes et al, 2004). Specific indications can only be discussed by choosing a 
selected number of essential oils. 
In Australia, three surveys showed that up to 1% of cancer patients used aromatherapy (Girgis et al, 2005, Salminen et 
al, 2004, Correa-Velez et al, 2003). In Canada, two surveys revealed that up to 4% of cancer patients used it (Tough et al, 2002, 
McKay et al 2005). In Italy, Spain and Turkey prevalence ranges from <1 to 2% (Johannessen et al, 2008, Fernandez-Ortega et al, 
2008, Akyuz et al, 2007).  In contrast, six surveys carried out in the UK showed that 40.6% of cancer patients were using it 
(Lewith et al., 2002, Maher et al., 1994, Rees et al., 2000, Harris et al., 2003, Scott et al., 2005, Shakeel et al., 2008). A US survey 
revealed that 11% of cancer patients may be using aromatherapy and in New Zealand 6% (Lawsin et al., 2007, Chrystal et al., 
2003). However, it is unclear whether this usage is a specific anti-cancer intervention or simply to increase general well-being and 
thus life-style associated rather than a therapeutic approach. One could assume that a similar percentage of healthy individuals is 
using essential oil, too.  
Since aromatherapy can also be applied orally or rectally, the administration of such oils may not be legally permitted in 
several countries, unless it is applied by a medically qualified person. There may be legal issues resulting from the fact that 
diluted essential oils can “penetrate the skin”, which could be considered as administering a drug. This review was carried out as a 
project for the European CAM cancer consortium (www.cam-cancer.org) and includes studies which assess the effect of 
aromatherapy on its own or in conjunction with massage therapy. The objective of this paper is to provide an updated review of 
evidence from pre-clinical and clinical trials assessing the benefits and safety of aromatherapy for cancer patients. 
 
Methods 
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Literature databases such as Medline (via Ovid), the Cochrane database of systematic reviews, Cochrane Central were  
searched from their inception until October 2010. The main search terms were ‘aromatherapy’ AND ‘cancer’. For specific 
literature search procedures see Table 1 (OVID) and Table 2 (Cochrane Central and Cochrane database of systematic reviews). 
As this review was supposed to be comprehensive, we decided to also include results from pre-clinical studies on cancer cells. 
Thus, studies on cancer cells or cancer patients were included. The quality of publications was assessed by looking at the internal 
validity (study design and conduct), external validity (applicability and generalizability of results) and summarizing the direction 
of evidence (positive, uncertain, negative). 
 
 
Results 
 
One systematic review, 18 clinical trials and a selected number of pre-clinical trials are summarized here. Further data 
are presented in Tables 3 and 4. Safety aspects are also discussed. 
 
Systematic reviews 
 
Yim et al (2009) carried out a systematic review specifically including trials for aromatherapy for depression (Yim et 
al., 2009). They included six studies applying aromatherapy massage in patients with depression. Three of the included studies 
evaluated the benefit of Swedish massage (two with lavender oil) for depressive symptoms of patients with cancer (mainly 
women with breast cancer). Results showed significant short term-improvement in anxiety and/or depression compared with usual 
care. No effect sizes were described. According to the authors this might be explained by an induction of a relaxation response in 
the autonomic nervous system. However, there was no adequate control intervention (i.e., massage without essential oils), and 
thus the relevance of this finding remains elusive.  
 
Clinical trials 
 
All clinical studies which applied essential oils with or without massage to cancer patients were included. For the data 
selection process see flow diagram. A total of 18 clinical studies have been included in this review (Barclay et al., 2006; Chang 
2008; Corner et al., 1995; Evans, 1995; Graham et al., 2003; Gravett, 2001a,b; Hadfield, 2001; Imanishi et al., 2009; Kirshbaum 
1996, Kite et al., 1998, Louis & Kowalski 2002, Maddocks-Jennings et al., 2009, Soden et al., 2004, Stringer et al., 2008, Wilcock 
et al., 2004; Wilkinson et al., 1999; Wilkinson et al., 2007). Nine are randomised controlled studies (Barclay et al., 2006; Chang 
2008; Corner et al., 1995; Maddocks-Jennings et al., 2009; Soden et al., 2004; Stringer et al., 2008; Wilcock et al., 2004; 
Wilkinson et al., 1999; Wilkinson et al., 2007), two are controlled (Graham et al., 2003; Louis and Kowalski 2002), three are 
uncontrolled (Gravett, 2001a,b; Hadfield, 2001) and four are case series (Evans, 1995; Imanishi et al., 2009; Kirshbaum, 1996; 
Kite et al., 1998) (see Table 3). The evidence of these trials points to a short-term benefit of aromatherapy / essential oils which 
could possibly last up to 2 weeks with reduction in anxiety and depression scores, improved sleep and an overall increase in 
wellbeing. Some of these trials also found an increase in patient-identified symptom relief and psychological wellbeing. However, 
other trials did not report any significant difference between groups. Since the comparator interventions used in the included trials 
vary greatly, it is not possible to assess the system and component efficacy of specific essential oils. The quality of publications 
ranged from mediocre to low. Double-blinding is practically impossible in the field of aromatherapy.   
In conclusion, existing evidence provides weak evidence that aromatherapy might have some short-term effects on 
anxiety and depression, and possibly on pain relief. However, it is unclear whether this is a matter of positive expectation or a 
pharmacologically mediated effect. 
 
Pre-clinical trials 
 
There is considerable published research available on the in vivo and in vitro anti-inflammatory, anti-oxidant, 
antibacterial, antifungal, and antiviral activity of a number of essential oils. Furthermore, the cytotoxic, free radical scavenging, 
carcinogenetic, apoptosis inducing and anti-neoplastic effects of a number of essential oils has been investigated in pre-clinical 
trials (Gould, 1997). For a summary of the selected pre-clinical studies see Table 4 (Abe et al., 2003; de Sousa et al., 2004; 
Legault et al., 2007; Ait Mbarek et al., 2007a, b; Horvathova et al., 2007; Atsumi et al., 2007; Banerjee et al., 1994; Li et al., 
2004; Xiao et al., 2008; Paik et al., 2005; Crowell et al., 1992). However, the concentrations applied in the respective studies 
might not be comparable to those in conventional aromatherapy, either volatile or directly resorbed. 
 
Safety aspects 
 
It is generally accepted by aromatherapists that a safe and effective dilution for most aromatherapy/essential oils in  
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Table 1: OVID search strategy and results 
Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1950 to Present 
ID Search Hits 
1 exp Neoplasms/ 2130453 
2 exp Lymphoma/ 127705 
3 exp Leukemia/ 174262 
4 exp Carcinoma/ 404411 
5 (cancer* or carcino* or tumor* or tumour* or neoplasm*).ti,ab. 1625323 
6 (leukaemi* or leukemi*).ti,ab. 176119 
7 malign*.ti,ab. 324193 
8 lymphoma*.ti,ab. 105030 
9 Antineoplastic.ti,ab. 10777 
10 
(melanoma* or sarcoma* or adenosarcoma* or adenocarcinoma* or 
carcinosarcoma* or chrondosarcoma* or fibrosarcoma* or dermatofibrosarcoma* 
or neurofibrosarcoma* or hemangiosarcoma* or leimyosarcoma* or liposarcoma* 
or lymphangiosarcoma* or myosarcoma* or rhabdomyosarcoma* or 
myxosarcoma* or osteosarcoma*).ti,ab. 223542 
11 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 2541534 
12 exp Aromatherapy/ 413 
13 aromatherapy.ti,ab. 424 
14 aroma therapy.ti,ab. 22 
15 (essential adj oil*).ti,ab. 4468 
16 12 or 13 or 14 or 15 4937 
17 11 and 16 236 
18 Controlled clinical trial.pt. 81735 
19 Randomized controlled trials/ 67475 
20 Random allocation/ 68683 
21 Double-blind method/ 106970 
22 Single-blind method/ 14058 
23 Clinical trial.pt. 462751 
24 exp Clinical Trial/ 614064 
25 (clinic* adj25 trial*).ti,ab. 182717 
26 ((singl* or doubl* or trebl* or tripl*) adj (mask* or blind*)).ti,ab. 106315 
27 Placebos/ 28936 
28 Placebo*.ti,ab. 126927 
29 Random.ti,ab. 126298 
30 Research design/ 59472 
31 Comparative study/ 1486610 
32 exp evaluation studies/ 135441 
33 Follow-up studies/ 405615 
34 Prospective studies/ 281016 
35 (control* or prospective* or volunteer*).ti,ab. 2297164 
36 Cross-over studies/ 26085 
37 systematic review.ti,ab. 19995 
38 meta-analysis.ti,ab. 24945 
39 
18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 
32 or 33 or 34 or 35 or 36 or 37 or 38 4331158 
Boehm et al., Afr J Tradit Complement Altern Med. (2012) 9(4):503-518 
Publisher: African Networks on Ethnomedicines 
Web page: /http://journals.sfu.ca/africanem/index.php/ajtcam/index 
http://dx.doi.org/10.4314/ajtcam.v9i4.7 
507
40 17 and 39 81 
Table 2: Cochrane Central and Cochrane database of systematic reviews 
ID Search Hits 
#1 MeSH descriptor Neoplasms explode all trees 40125 
#2 MeSH descriptor Lymphoma explode all trees 1878 
#3 MeSH descriptor Leukemia explode all trees 2738 
#4 MeSH descriptor Carcinoma explode all trees 6882 
#5 (cancer* or carcino* or tumor* or tumour* or neoplasm*):ti,ab 54094 
#6 (leukaemi* or leukemi*):ti,ab 5225 
#7 malign*:ti,ab 5697 
#8 lymphoma*:ti,ab 3255 
#9 Antineoplastic:ti,ab 290 
#10 
(melanoma* or sarcoma* or adenosarcoma* or adenocarcinoma* or 
carcinosarcoma* or chrondosarcoma* or fibrosarcoma* or dermatofibrosarcoma* 
or neurofibrosarcoma* or hemangiosarcoma* or leimyosarcoma* or liposarcoma* 
or lymphangiosarcoma* or myosarcoma* or rhabdomyosarcoma* or 
myxosarcoma* or osteosarcoma*):ti,ab 3610 
#11 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10) 72033 
#12 MeSH descriptor Aromatherapy explode all trees 78 
#13 aromatherapy:ti,ab 94 
#14 aroma therapy:ti,ab 10 
#15 (essential NEXT oil*):ti,ab 172 
#16 (#12 OR #13 OR #14 OR #15) 262 
#17 (#11 AND #16) 21 
 
 
 
massage therapy is a maximum of 2.5 % for adults, which translates to 2 drops of essential oil per 100 drops of carrier oil (2% 
dilution: 10-12 drops of essential oil per ounce of carrier oil). For full-body baths, the dosage of essential oil is usually 5–10 drops 
per bath. As long as practitioners know how to dilute them, non-toxic essential oils used on the skin are unlikely to harm the 
patient. 
The testing of essential oils for safety has shown minimal adverse effects. A number of oils have therefore been 
approved for use as food additives and are classified as GRAS (generally recognized as safe) by the U.S. Food and Drug 
Administration (US Food and Drug Administration). There is, however, a risk involved with ingestion of large amounts of 
essential oils. For instance, severe, extensive, life threatening phototoxic reactions, such as the case of a woman who died of a 
massive phototoxic skin reaction, have been described after ingestion of food and medication containing psoralen and subsequent 
exposure to artificial UV radiation (Kaddu et al., 1998). 
Some essential oils (e.g. camphor oil) can cause local irritation. The main safety issue with essential oils seems to be 
that cases of contact dermatitis have been reported, mostly in aromatherapists who have had prolonged skin contact with oils in 
the context of aromatherapy massage. In a mailed 2004 survey including members of a national massage therapy organization in 
the greater Philadelphia region found that the 12-month prevalence of hand dermatitis in subjects was 15% by self-reported 
criteria and 23% by a symptom-based method (Crawford et al., 2004). This problem had also been reported much earlier in the 
UK (Bilsland and Strong, 1990). 
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Figure 1: Flow diagram 
 
 
It has been suggested that since fragrance ingredients are still major causes of allergic contact dermatitis, the 
concentration of essential oils and materials with unknown composition can be problematic (Jansson and Loden 2001). Moreover, 
phototoxicity may occur when essential oils (particularly citrus oils) are applied directly to the skin before sun exposure (Kaddu 
2001). Individual psychological associations with odors may result in adverse responses, especially if the memory of a scent 
provokes strong emotions (Holmes and Ballard 2004).  
Repeated exposure to lavender and tea tree oils by topical administration was shown in one study to be associated with 
reversible prepubertal gynecomastia (Henley et al., 2007). The respective effect appears to have been caused by the purported 
weak estrogenic and antiandrogenic activities of lavender and tea tree oils. Therefore, these two essential oils could cause 
problems in patients with estrogen-dependant tumors. A review on the safety assessment of St John’s Wort (Hypericum 
perforatum) oil concluded that the available data are insufficient to support the safety of ingredients from this plant in cosmetic 
formulations (Anonymous, 2001).     
 
 
Discussion 
 
Findings on the interventional use of aromatherapy in cancer patients suggests a short-term benefit to reduce anxiety and 
depression, improve sleep and increase overall wellbeing; this effect has been suggested to last up to 2 weeks. Some of the trials  
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Table 3: Results – extracted data of included studies  
First author, year Type of study Participants  
(diagnosis, N) 
Arms Intervention groups,  
Duration of application,  
Time of follow-up 
Results (sig.) Comments  
 
Barclay, 2006 RCT Lymphedema, 81 2 (1) Aromatherapy and massage 
(2) Massage therapy alone 
Daily self-massage of limb(s) 
6 months 
Increase in patient-identified 
symptom relief (MYMOP) after 
6 months (p<0,001) and 
wellbeing (P=0.003) 
Essential oils did not 
influence improvements 
in selected outcome 
measures 
Chang, 2008 RCT Terminally ill patients 
with various cancer types, 
58 
2 (1) Aromatherapy hand massage 
(Bergamot, Lavender, Frankincense) 
(2) General oil hand massage 
5 mins for 7 days 
1 week 
(1) showed more significant 
changes in pain (P=0.001) and 
depression scores (P=0.000) 
Aromatherapy hand 
massage had positive 
effect on pain and 
depression 
Corner, 1995 RCT Various types of cancer, 
51 
2 (1) Massage with an essential oil 
mix  
(2) Massage with carrier oil 
30 min sessions weekly for 8 weeks 
2 months 
Anxiety scores (HADS) were 
significantly reduced over time 
in the massage with essential oils 
group only (p<0.05) 
Patients in both groups 
improved over time 
according to the 
symptom distress scale 
Evans, 1995 Case series Various types of cancer, 
69 
Na Application of various oils and 
massage therapy 
Not reported 
Not  reported 
General improvement in 
symptoms reported 
 
No p-values provided 
Graham, 2003 CCT Various types of cancer, 
313 
3 (1) Aromatherapy including carrier 
oil with fractionated oils 
(2) carrier oil only 
(3) pure essential oils (lavender, 
bergamot, cedar wood) 
15-20 min exposure to oils on bib 
One-off treatment during 
radiotherapy 
Group (2) had significantly 
reduced anxiety scores after 
treatment as measured with 
HADS (P=.04) 
Aromatherapy as 
administered in this 
particular trial was not 
beneficial to cancer 
patients 
Gravett, 2001 UCT ? Na Effect of essential oils such as 
lavender, eucalyptus (Eucalyptus 
globulus Labill. and Eucalyptus 
radiata Sieber ex DC. [Myrtaceae]), 
and tea tree oil was measured on 
incidence of infections 
Not reported 
Not reported 
No effects were observed No patient-generated 
data from validated 
outcome measures and 
no baseline assessment 
Gravett, 2001 UCT ? Na Orally applied geranium 
(Pelargonium species), German 
chamomile (Matricaria recutita L. 
[synonyms: Matricaria chamomilla 
L., Chamomilla recutita (L.) 
Rausch.]), patchouli (Pogostemon 
cablin [Blanco] Benth. [Lamiaceae] 
No effect of essential oils on 
cancer-related symptoms. 
Also, no effects on 
gastrointestinal symptoms 
No patient-generated 
data from validated 
outcome measures and 
no baseline assessment 
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[synonyms: Mentha cablin Blanco, 
Pogostemon patchouly Letettier]), 
and turmericphytol 
Not reported 
Not reported 
Hadfield, 2001 UCT Malignant brain tumor, 8 Na Aromatherapy massage (lavender or 
Roman chamomile) and Enya music 
30 min, one-off treatment 
24 hours 
Decrease in systolic and diastolic 
blood pressure, heart and 
respiratory rate 
Semi-structured 
interviews carried out 
one week after 
treatment revealed that 
patients felt more 
‘relaxed’ and ‘less 
tense’ 
Imanishi, 2009 Case series Mamma carcinoma, 12 Na 30 min aromatherapy massage twice 
a week for 4 weeks 
1 month 
STAI was reduced after a 30 min 
aromatherapy massage and also 
reduced in 8 sequential 
aromatherapy massage sessions 
in the HADS (P=0.01). 
Aromatherapy massage 
may ameliorated the 
immunologic state 
Kirshbaum, 1996 Case series Mamma carcinoma with 
lymphedema, 8 
Na 20-30 minute aromatherapy massage 
with lavender oil 
Up to 6 sessions 
Length of follow-up not reported 
Reported alleviation of pain, 
noticeable reduction in swelling, 
increase in overall comfort and a 
feeling of relaxation  
 
No p-values provided 
Kite, 1998 Case series Various types of cancer, 
89 
Na 6 sessions of aromatherapy massage 
Not reported 
Not reported 
Improvement in HADS scores (P 
< 0.001) as well as symptoms 
from before baseline to after 
treatment 
- 
Louis, 2002 CCT (same 
group, repeated 
measure design) 
Various types of cancer, 
17 
3 (1) Water humidification 
(2) aromatherapy with lavender  
(3) no treatment 
60 min, one-off session 
1 week 
(1) and (2) showed a small 
reduction in blood pressure and 
pulse rate; decrease in pain, 
anxiety, depression scores; and 
an increase in overall wellbeing  
Repeated lavender 
aromatherapy sessions 
might increase its 
benefits even more. 
No p-values provided 
Maddocks-Jennings RCT Head and neck cancer 
patients, 19 
3 (1) Essential oil gargle (manuka, 
kanuka mixture) 
(2) placebo gargle 
(3) standard care 
Gargling for at last 15 sec, 30 min 
before/after eating, drinking, 
smoking, radiotherapy 
From day of radiotherapy or 2 days 
before until 1 week after 
(1) had delayed onset of 
mucositis (p=0.05) and reduced 
pain (no p-value) and oral 
symptoms (no p-value) 
compared to (2) and (3) 
(1) showed less weight loss (no 
p-value) 
Small volumes of 
manuka and kanuka 
used in a gargle can 
provide positive effect 
on radiation-induced 
mucositis. 
Small sample size, few 
p-values provided 
Soden, 2004 RCT Various types of cancer, 
42 
3 Massages with 
(1) an essential oil and an inert 
carrier oil 
(2) an inert carrier oil only 
(3) no intervention 
Sleep scores improved 
significantly in both groups (1) 
and (2) (P=0.02 and P=0.03); 
Reductions in depression scores 
in (2) (P=0.2) 
Addition of lavender 
essential oil did not 
appear to increase the 
beneficial effects of 
massage 
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30 min weekly 
1 month 
Stringer, 2008 RCT Patients with 
haematological cancer, 39 
3  (1) massage / light effleurage 
(stroking) moves 
(2) max of 3 aromatherapy oils with 
carrier oil, individualized 
(3) rest 
20 min, one-off 
24 hours 
 
Significant difference between 
arms in cortisol (p=0.002) and 
prolactin 
(p=0.031) levels from baseline to 
30 min post-session 
(1) had a 
significantly greater reduction in 
prolactin than (2), (3) (p=0.031) 
(1) and (2) showed significant 
improvement in EORTC QLQ-
C30 (p=0.009) 
In isolated 
haematological 
oncology patients, 
a significant reduction 
in cortisol could be 
safely achieved through 
aromatherapy, with 
associated 
improvement in 
psychological well-
being 
Wilcock, 2004 RCT Various types of cancer, 
46 
2 (1) Aromatherapy massage and 
conventional day care 
(2) day care alone 
30 min weekly for 4 weeks 
1 month 
No significant differences for 
mood, quality of life and 
intensity and bothersomeness of 
two main symptoms 
Better set of outcome 
measures ought to be 
used for a larger RCT. 
Problem with retention 
of patients  
Wilkinson, 1999 RCT Various types of cancer, 
103 
2 (1) Aromatherapy massage (roman 
chamomile essential oil)  
(2) carrier oil massage 
“session” weekly for 3 weeks 
1 ½ months 
Improvements were found for 
each group measured with STAI-
state (p < 0.001). Scores of group 
(1) improved on all RSCL 
subscales at the 1% level of 
significance or better: 
psychological (p < 0.001), 
quality of life (p < 0.01), severe 
physical (p < 0.05), and severe 
psychological (P < 0.05), except 
for severely restricted activities 
Massage with or 
without essential oils 
appeared to reduce 
levels of anxiety. 
The addition of an 
essential oil seems to 
enhance the effect of 
massage and to improve 
physical and 
psychological 
symptoms, as well as 
overall quality of life 
Wilkinson, 2007 RCT Various types of cancer 
and clinical diagnosis of 
anxiety and/or depression, 
288 
2 (1) Aromatherapy massage 
(2) Standard care 
Weekly 1 hour massage for 4 weeks 
2 ½ months 
Group (1) showed significant 
improvement in clinical anxiety 
and/or depression compared with 
(2) at 6 weeks (P=0.1), but not at 
10 weeks post randomization.  
(1) also described greater 
improvement in self-reported 
anxiety at both 6 and 10 weeks 
post-randomization (P=0.04 and 
P=0.04) 
Aromatherapy massage 
did not appear to confer 
benefit on cancer 
patients’ anxiety and/or 
depression in the long-
term, but may be 
associated with 
clinically important 
benefit up to 2 weeks 
after the intervention 
RCT – randomized clinical trial, CCT – clinical controlled trial, UCT – uncontrolled clinical trial 
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Table 4: Results – preclinical studies 
RefNo Type of study Focus of study NA Type of aromatherapy Results Conclusion  
Anti-inflammatory activity 
45 in vitro study 
to test the anti-inflammatory  
activities and effects of essential 
oils on neutrophil activation in vitro  NA 
lemongrass, geranium and  
spearmint oils, amongst others 
inhibitory activities for the 
neutrophil adherence were 
obtained by the major 
constituent terpenoids of citral, 
geraniol and carvone essential 
oils but not tea tree or lavender 
oil   
Anti-oxidant activity 
46 in vitro study 
to test the antioxidant activity of  
the oil Melissa officinalis L. (lemon 
balm)  NA 
Melissa officinalis L.  
(lemon balm)  
oil was very effective against  
a series of human cancer cell 
lines  
Melissa officinalis L.  
essential oil might be a  
potential anti-tumoral agent  
Anti-cancer activity 
47 in vitro study 
to assess the potentiating effect of 
beta-caryophyllene on the 
anticancer activity of alpha-
humulene agianst human cancer 
cells NA 
isocaryophyllene (clove oil), 
Humulus lupulus (hops), hemp 
(Cannabis sativa), rosemary 
(Rosmarinus officinalis) 
beta-caryophyllene promotes  
drug accumulation by a 
different mechanism of action 
and facilitates the passage of 
paclitaxel through the 
membrane 
beta-caryophyllene potentiates 
 its anticancer activity  
Cytotoxicity 
    48, 49 
in vitro, mouse 
model to assess cytotoxocity NA 
Nigella sativa L. (blackseed) and 
Thymus broussonetti (thyme) 
essential oil showed significant 
in vitro cytotoxicity activity 
against tumor cells resistant to 
chemotherapy as well as a 
significant antitumor effect in 
mice 
cytotoxicity of each extract 
depended on the tumor cell 
type  
50 in vivo and in vitro to assess cytotoxocity NA 
eucalyptol, carvacrol and  
thymol  
Carvacrol and thymol 
significantly 
 reduced the level of induced 
DNA damage  
DNA-protective effects of 
carvacrol and thymol can be 
accompanied by their 
antioxidant action  
Free radical scavenging activity 
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51 UCT 
to examine the saliva of 22 human 
 volunteers who had sniffed the 
aroma of lavender or rosemary 22 lavender, rosemary 
free radical scavenging activity
 values were increased by 
stimulation with low 
concentrations of lavender or 
by high concentrations of 
rosemary 
both essential oil stimulations 
decreased cortisol levels  
aromatherapy might have 
 an effect on people by 
decreasing the stress hormone 
cortisol  
Carcinogenesis / Carcinogen-metabolizing enzymes 
52 mouse model 
to test the influence of essential oils 
on carcinogen-metabolizing 
enzymes and acid-soluble 
sulfhydryls  NA 
cardamom, celery seed, cumin 
 seed, coriander, ginger, nutmeg 
and zanthoxylium 
only nutmeg and zanthoxylium 
oils induced cytochrome P450 
level significantly                     
cardamom oil caused a 
significant reduction in its 
activity 
aryl hydrocarbon hydroxylase 
activity was significantly 
elevated  by treatment with 
ginger oil, whereas nutmeg oil 
caused a significant reduction 
in its activity 
oral intake of essential oils 
 seems to affect the host 
enzymes associated with 
activation and detoxication of 
xenobiotic compounds, 
including chemical carcinogens 
and mutagens  
Apoptosis 
53 in vitro 
to test morphological changes of 
classic apoptosis  NA Artemisia annul L. (wormwood)  
condensation of cytoplasm, 
fragmentation of nuclear 
chromatin, and apoptosis body 
was seen in cultured 
hepatocarcinoma cell SMMC-
7721 (human hepatoma cell 
line) 
Artemisia annul L. could 
indeed induce apoptosis of 
cultured SMMC-7721  
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54 in vitro to test for apoptosis NA Curcuma wenyujin (turmeric root) 
was found to inhibit the growth
 of HepG2 cells in a dose-
dependent manner and by 
inducing a cell cycle arrest in 
human HepG2 cancer cells 
Curcuma wenyujin exhibits 
 an anti-proliferative effect in 
HepG2 cells by inducing 
apoptosis  
55 in vitro and in vivo  NA 
Zanthoxylum schinifolium (prickly 
ash or Korean pepper)  
decreased the cell viability and
 induced apoptotic death in 
HepG2 human hepatoma cells;
in nude mice inoculated with 
Huh-7 human hepatoma cells, 
the extract significantly 
inhibited tumor development 
potential candidate for  
hepatocellular carcinoma 
therapy   
Chemo-preventative/antineoplastic  
56 in vivo    
to test for chemo-preventive and  
therapeutic effects  NA limonene  
that limonene exhibits both  
chemo-preventive and 
therapeutic effects against 
chemically induced mammary 
tumors in rats 
possible candidate for  
chemopreventative agent  
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also found an increase in patient-identified symptom relief and psychological wellbeing. However, other trials did not report 
any significant difference between groups. Since the comparator interventions used in the included trials vary greatly, it was 
not possible to make an easy assessment regarding the system and component efficacy of specific essential oils. Although 
there were some RCT, the quality of publications ranges from mediocre to low. In particular, double-blinding as a quality 
marker of clinical trials is nearly impossible in trials in the field of aromatherapy, and thus study quality tends to be lower 
compared to conventional pharmacological trials. Moreover, adequate control interventions are needed. For example, 
massage therapy generally has a positive effect on the recipient and most positive effects discussed above stem from trials 
that in adjunction apply essential oils. Thus, it is difficult to be certain as to where exactly the reason for a positive effect lies. 
However, wellbeing and offering these effects in a package are of limited harm and thus some cancer clinics or other 
voluntary organizations now offer aromatherapy or aromatherapy massage free of charge or at a lower cost.  
The cost of essential oils varies depending on the quality, i.e. what part of the plant the oil is extracted from and 
which method that was used to extract it. Oils may be purchased from a licensed aromatherapist. For instance, essential oil 
from rose petals retails at €100 per ounce (appr. 28 grams) - based on the 110 pounds (50 kg) of rose petals needed for a 
single ounce of essential oil. Other plants retail at much lower prices as they yield more essential oil (for instance lavender, 
lemon, and eucalyptus). Lavender can be bought at €22 per ounce. Treatments of aromatherapy usually are priced from €40 
to €75 for a 90 minute session.  
The number of theories that try to explain the mechanism of aromatherapy can be categorized into psychological 
aspects and neuro-chemical effects. Proposed mechanisms claim effects on the limbic and olfactory system, which in turn is 
suggested to have an effect on mood (Diego et al., 1998). However, only very limited research confirms effectiveness or 
mechanism of action and in-depth studies have yet to shed sufficient light on these possible mechanisms and the connection 
between the olfactory and limbic system. Proponents of essential oils / aromatherapy also believe that the effects these oils 
have on the body are greater than the sum of the individual components of the scents (Perry and Perry, 2006).  Furthermore, 
there are various discussions amongst aromatherapists as to whether natural oils are superior to synthetic ones. Currently, 
there are no references to scientific studies of the issue. 
 
Limitations 
 
The limitations of this descriptive, systematic review include the fact that despite modern search engines and well- 
organized literature databases sometimes it is impossible to identify all the ‘grey literature’ regarding one topic. Thus, it is 
possible that the one or other study or case series is not included in this review. For instance, the medical search engine 
EMBASE was not searched. Furthermore, outcome measures and study designs of included studies varied to an extent that 
meta-analyzing the data was omitted due to heterogeneity.  
As providers of essential oils are numerous and widespread in countries where aromatherapy is practiced, mainly 
on the European, North American, Australasian and Asian continents, comparability in trials with the same substance still 
may result in different outcomes. Moreover, training of aromatherapists and courses offered by some colleges and schools do 
not have a concerted curriculum which also includes a potential source of bias. 
 
Conclusion 
 
In summary, the use of diluted essential oils has minimal risks. Prolonged topical application may nevertheless 
cause allergic contact dermatitis. Repeated exposure to lavender and tea tree oils by topical administration was shown in one 
study to be associated with reversible prepubertal gynecomastia. Thus, patients with estrogen-dependant tumors should 
exercise caution. Aromatherapy/essential oils may be used safely by cancer patients for a short-term benefit in regard to 
reducing anxiety and depression symptoms and to increase sleep patterns and wellbeing. 
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